Researchers
Vučićević, Katarina
Results 61-80 of 203
| Issue Date | Title | Author(s) | Type | Мp-cat. |
|---|---|---|---|---|
| 2022 | Zabrinutost u vezi sa primenom lekova kod pacijenata sa hroničnim respiratornim oboljenjima | Kovačević, Milena | Conference Paper | Mp. category will be shown later |
| 2022 | Application of adjusted indirect comparisons to assess bioequivalence and switchability between generic drugs – example of clopidogrel | Pejčić, Zorica; Vučićević, Katarina | Conference Paper | Mp. category will be shown later |
| 2021 | Concept and utility of population pharmacokinetic and pharmacokinetic/ pharmacodynamic models in drug development and clinical practice | Roganović, Maša | Article | 52M52 |
| 2021 | A Mechanistic In Vivo/Ex Vivo Pharmacokinetic-Pharmacodynamic Model of Tenofovir for HIV Prevention | Jayachandran, Priya; Garcia-Cremades, Maria; Vučićević, Katarina | Article | 21M21 |
| 2021 | Population pharmacokinetic modelling of cyclosporine in paediatric kidney transplant patients using routine TDM data![]() | Roganović, Maša | Conference Paper | Mp. category will be shown later |
| 2021 | The influence of biologically effective dose (BED) on the 131I therapy response in patients with benign thyroid disease – nonlinear mixed effect modelling approach![]() | Topić Vučenović, Valentina; Rajkovača, Zvezdana; Jelić, Dijana; Stanimirović, Dragi; Mikov, Momir | Conference Paper | Mp. category will be shown later |
| 2021 | Population exposure-response model of 131I in patients with benign thyroid disease | Topić-Vučenović, Valentina; Rajkovača, Zvezdana; Jelić, Dijana; Stanimirović, Dragi; Mikov, Momir | Article | 21aM21a |
| 2021 | Population pharmacokinetic-pharmacogenetic (PopPK-PGx) model of efavirez in HIV-1-infected Serbian patients![]() | Vučićević, Katarina | Conference Paper | Mp. category will be shown later |
| 2021 | Predicting Hiv Risk and Protective Tenofovir Concentration: a Pooled Analysis from Hiv Pre-Exposure Prophylaxis Trials. | Garcia-Cremades, Maria; ...; Vucicevic, Katarina M | Conference Paper | Mp. category will be shown later |
| 2021 | Quality indicators for measuring the level of patients' involvement in the pharmaceutical care process | Vučićević, Katarina | Article | 23M23 |
| 2020 | Impact of gastrointestinal physiology on drug absorption in special populations––An UNGAP review![]() | Stillhart, Cordula; Vučićević, Katarina | Article | 21aM21a |
| 2020 | Population pharmacokinetic model of Vancomycin based on therapeutic drug monitoring data in critically ill septic patients | Kovacevic, Tijana; Miljković, Branislava | Article | 22M22 |
| 2020 | Inhaler technique training of community pharmacists and common errors | Milenković, Branislava | Conference Paper | Mp. category will be shown later |
| 2020 | Understanding variability in the pharmacokinetics of atypical antipsychotics - focus on clozapine, olanzapine and aripiprazole population models | Jovanovic, Marija N; Vucicevic, Katarina M | Article | 21aM21a |
| 2020 | Clinical pharmacokinetics of methotrexate in the treatment of acute lymphoblastic leukemia and non-Hodgkin lymphoma in pediatric patients | Škorić, Biljana; Jovanović, Marija | Article | 51M51 |
| 2019 | The importance of pembrolizumab and nivolumab pharmacokinetics in the treatment of oncology patients | Vučićević, Katarina | Conference Paper | Mp. category will be shown later |
| 2019 | Association of Nrf2, SOD2 and GPX1 Polymorphisms
with Biomarkers of Oxidative Distress and Survival
in End-Stage Renal Disease Patients![]() | Jerotić, Đurđa | Article | 21aM21a |
| 2019 | Exploring sirolimus pharmacokinetic variability using data available from the routine clinical care of renal transplant patients - population pharmacokinetic approach - populacioni farmakokinetički pristup | Golubović, Bojana; Vučićević, Katarina | Article | 22M22 |
| 2019 | Individual level data meta-analysis from HIV pre-exposure prophylaxis (PrEP) clinical trials | Garcia-Cremades, Maria; Vučićević, Katarina
Glidden, David; Savić, Radojka M.;
| Conference Paper | Mp. category will be shown later |
| 2019 | Clinically important drug interactions with opioid and non-opioid analgesics | Vezmar-Kovačević, Sandra | Article | 52M52 |
